-
Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Tuesday, July 9, 2024 - 12:26pm | 454Tempus AI Inc (NASDAQ:TEM) announced last week it was granted advanced diagnostic laboratory test status for its next-generation sequencing assay. These analysts provide their initial takeaways from the stock. BofA Securities On Tempus Analyst Michael Ryskin initiated coverage with a Buy rating and...
-
SolarEdge Technologies' Shares Are Trading At 5-Year Lows: Analyst Expects 'Return To Profitability' In 2025
Monday, July 8, 2024 - 11:37am | 353Shares of SolarEdge Technologies Inc (NASDAQ:SEDG) spiked in early trading on Monday, after plummeting over the past month on the company's announcement of a $300 million private offering. The stock is trading at five-year lows, following the second-quarter guidance miss, underperforming Enphase...
-
Canopy Growth Shares Are Trading Higher Today, Analysts Tell Us Why
Wednesday, February 9, 2022 - 11:26am | 517Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) reported its financial results Wednesday for the third quarter fiscal 2022 ended December 31, 2021, revealing a decline of 8% sequentially in net revenue to CA$141 million (US$111.12 million). Cantor Fitzgerald’s analyst Pablo...